Scientific Articles Oncology

226.
Latosinska A, Makridakis M, Frantzi M, Borràs DM, Janssen B, Mullen W, Zoidakis J, Merseburger AS, Jankowski V, Mischak H, Vlahou A.
Integrative analysis of extracellular and intracellular bladder cancer cell line proteome with transcriptome: improving coverage and validity of -omics findings.
Sci Rep. 2016 May 11;6:25619. doi: 10.1038/srep25619.

View AbstractDownload     Request Reprint

 

231.
Bhat A, Mokou M, Zoidakis J, Jankowski V, Vlahou A, Mischak H.
BcCluster: A Bladder Cancer Database at the Molecular Level.
Bladder Cancer. 2016 Jan 7;2(1):65-76.

View AbstractDownload     Request Reprint

 

223.
Frantzi M, Van Kessel KE, Zwarthoff EC, Marquez M, Rava M, Malats N, Merseburger AS, Katafigiotis I, Stravodimos K, Mullen W, Zoidakis J, Makridakis M, Pejchinovski M, Critselis E, Lichtinghagen R, Brand K, Dakna M, Roubelakis MG, Theodorescu D, Vlahou A, Mischak H, Anagnou NP.
Development and validation of urine-based peptide biomarker panels for detecting bladder cancer in a multi-center study.
Clin Cancer Res. 2016 Mar 29. pii: clincanres.2715.2015. [Epub ahead of print]

View AbstractDownload     Request Reprint

 

 

217.
Latosinska A, Vougas K, Makridakis M, Klein J, Mullen W, Abbas M, Stravodimos K, Katafigiotis I, Merseburger AS, Zoidakis J, Mischak H, Vlahou A, Jankowski V.
Recent progress in urinary proteome analysis for prostate cancer diagnosis and management.
PLoS One. 2015 Sep 2;10(9):e0137048. doi: 10.1371/journal.pone.0137048. eCollection 2015.

View AbstractDownload     Request Reprint

 

206.
Frantzi M, Latosinska A, Flühe L, Hupe MC, Critselis E, Kramer MW, Merseburger AS, Mischak H, Vlahou A.
Developing proteomic biomarkers for bladder cancer: towards clinical application.
Nat Rev Urol. 2015 Jun;12(6):317-330. doi: 10.1038/nrurol.2015.100. Epub 2015 May 26. Review.

View AbstractDownload     Request Reprint

 

191.
Bhat A, Dakna M, Mischak H.
Integrating proteomics profiling data sets: a network perspective.
Methods Mol Biol. 2015;1243:237-53. doi: 10.1007/978-1-4939-1872-0_14.

View AbstractDownload     Request Reprint

 

168.
Neuhaus J, Schiffer E, Siwy J, Mannello F, Horn LC, Stolzenburg JU
Proteome-based diagnostic and prognostic biomarkers of prostate cancer.
Urologe A. 2013 Sep;52(9):1251-5. doi: 10.1007/s00120-013-3308-0.

View AbstractDownload     Request Reprint

167.
Latosinska A, Frantzi M, Vlahou A, Mischak H
Clinical applications of capillary electrophoresis coupled to mass spectrometry in biomarker discovery: Focus on Bladder Cancer.
Proteomics Clin Appl. 2013 Aug 23. doi: 10.1002/prca.201300038. [Epub ahead of print]

View AbstractDownload     Request Reprint

 

164.

Frantzi M, Zoidakis J, Papadopoulos T, Zurbig P, Katafigiotis I, Stravodimos K, Lazaris A, Giannopoulou I, Ploumidis A, Mischak H, Mullen WB, Vlahou A.
IMAC fractionation in combination to LC/MS reveals H2B and NIF-1 peptides as potential bladder cancer biomarkers.
J Proteome Res. 2013 Aug 7. [Epub ahead of print]

View AbstractDownload     Request Reprint

 

161.
Neuhaus J, Schiffer E, Wilcke P, Bauer HW, Leung H, Siwy J, Ulrici W, Paasch U, Horn LC, Stolzenburg J
Seminal Plasma as a Source of Prostate Cancer Peptide Biomarker Candidates for Detection of Indolent and Advanced Disease
PLoS ONE 8(6): e67514. doi:10.1371/journal.pone.0067514

View AbstractDownload     Request Reprint

 

140.
Metzger J, Negm AA, Plentz RR, Weismüller TJ, Wedemeyer J, Karlsen TH, Dakna M, Mullen W, Mischak H, Manns MP, Lankisch TO
Urine proteomic analysis differentiates cholangiocarcinoma from primary sclerosing cholangitis and other benign biliary disorders
Gut. 2013 Jan;62(1):122-30. doi: 10.1136/gutjnl-2012-302047. Epub 2012 May 12.

View AbstractDownload     Request Reprint

 

133.
Schiffer E, Bick C, Grizelj B, Pietzker S, Schöfer W
Urinary proteome analysis for prostate cancer diagnosis: Cost-effective application in routine clinical practice in Germany
Int J Urol. 2012 Feb;19(2):118-25. doi: 10.1111/j.1442-2042.2011.02901.x. Epub 2011 Nov 22.
        
View Abstract Download     Request Reprint

 

117.
Schiffer E
Urinary proteomics: ready for prime time in urological cancer diagnostics?
Personalized Medicine 2011, Jan;8 (1): 81-94
         
View Abstract Download currently not available      Request Reprint

 

114.
Lankisch TO, Metzger J, Negm AA, Voßkuhl K, Schiffer E, Siwy J, Weismüller TJ, Andrea S. Schneider AS, Thedieck K, Baumeister R, Zuerbig P, Weissinger EM, Manns MP, Mischak H, Wedemeyer J
Bile proteomic profiles differentiates cholangiocarcinoma from primary sclerosing cholangitis and choledocholithiasis
Hepatology. 2011 Mar;53(3):875-884. doi: 10.1002/hep.24103
         
View Abstract Download currently not available      Request Reprint

 

98.
Schiffer E.
The 2nd annual oncology biomarkers conference.
Biomark Med. 2009 Apr;3(2):203-9.
         
View Abstract      Request Reprint 

 

94.
Weissinger EM, Zürbig P, Ganser A.
Proteomics studies after hematopoietic stem cell transplantation.
Methods Mol Biol. 2009;506:437-52
         
View Abstract      Request Reprint 

 

93.

Schiffer E, Vlahou A, Petrolekas A, Stravodimos K, Tauber R, Geschwend JE, Neuhaus J, Stolzenburg JU, Conaway MR, Mischak H, Theodorescu D
Prediction of Muscle-invasive Bladder Cancer Using Urinary Proteomics
Clin Cancer Res. 2009 Aug 1;15(15):4935-43
         
View Publisher Website      Request Reprint   

 

86.
Weissinger EM, Mischak H, Kontsendorn J, Hahn A, Hahn N, Morgan M, Ganser A
Proteome analysis in hematology using capillary electrophoresis coupled on-line to mass spectrometry
Mini Rev Med Chem. 2009 May;9(5):627-3
         
View Publisher Website      Request Reprint   

62.
Schiffer E, Mischak H, Theodorescu, Vlahou A
Challenges of using mass spectrometry as a bladder cancer biomarker discovery platform
World Journal of Urology 2008, 26(1): 67-74
         
View Abstract      Request Reprint   

61.
Theodorescu D, Schiffer E, Bauer HW, Douwes F, Eichhorn F, Polley R, Schmidt T, Schöfer W, Zurbig P, Good DM, Coon JJ, Mischak H
Discovery and validation of urinary biomarkers for prostate cancer
PROTEOMICS - Clinical Applications 2008, 2(4): 556-570
         
View Abstract      Request Reprint   

55.
Schiffer E
Biomarkers for prostate cancer
World Journal of Urology 2007, 25(6): 557-562
         
View Abstract      Request Reprint   

47.
Wittke S, Schiffer E, Bauer HW
Kapillarelektrophorese gekoppelte Massenspektrometrie zur Proteomanalyse: Eine innovative diagnostische Methode bei Prostata- und Blasenkrebs
Der Urologe 2007, 46(7): 733-739
         
View Abstract      Request Reprint   

36.
Mischak H
Hochauflösende Proteomanalyse aus Urin in der nicht invasiven Diagnostik von Tumoren und chronischen Erkrankungen
prevention and anti aging 2006, 2(4): 426-435
         
View Abstract      Request Reprint   

31.
Theodorescu D, Wittke S, Ross MM, Walden M, Conaway M, Just I, Mischak H, Frierson HF
Discovery and validation of new protein biomarkers for urothelial cancer: a prospective analysis
Lancet Oncol. 2006, 7(3): 230-240
         
View Abstract      Request Reprint   

20.
Theodorescu D, Fliser D, Wittke S, Mischak H, Krebs R, Walden M, Ross M, Eltze E, Bettendorf O, Wulfing C, Semjonow A
Pilot study of capillary electrophoresis coupled to mass spectrometry as a tool to define potential prostate cancer biomarkers in urine
Electrophoresis. 2005, 26(14): 2797-2808
         
View Abstract      Request Reprint   

17.
Kolch W, Mischak H, Pitt AR
The molecular make-up of a tumour: proteomics in cancer research
Clin Sci (Lond). 2005, 108(5): 369-383
         
View Abstract      Request Reprint